154 related articles for article (PubMed ID: 32996013)
1. Increased O-GlcNAcylation induces myocardial hypertrophy.
Chen X; Zhang L; He H; Sun Y; Shen Q; Shi L
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):735-743. PubMed ID: 32996013
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.
Gélinas R; Mailleux F; Dontaine J; Bultot L; Demeulder B; Ginion A; Daskalopoulos EP; Esfahani H; Dubois-Deruy E; Lauzier B; Gauthier C; Olson AK; Bouchard B; Des Rosiers C; Viollet B; Sakamoto K; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S; Bertrand L
Nat Commun; 2018 Jan; 9(1):374. PubMed ID: 29371602
[TBL] [Abstract][Full Text] [Related]
3. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
[TBL] [Abstract][Full Text] [Related]
5. Sustained Increases in Cardiomyocyte Protein
Ha CM; Bakshi S; Brahma MK; Potter LA; Chang SF; Sun Z; Benavides GA; He L; Umbarkar P; Zou L; Curfman S; Sunny S; Paterson AJ; Rajasekaran NS; Barnes JW; Zhang J; Lal H; Xie M; Darley-Usmar VM; Chatham JC; Wende AR
J Am Heart Assoc; 2023 Oct; 12(19):e029898. PubMed ID: 37750556
[TBL] [Abstract][Full Text] [Related]
6. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
8. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
Marsh SA; Dell'Italia LJ; Chatham JC
Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
[TBL] [Abstract][Full Text] [Related]
9. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
10. Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes.
Ngoh GA; Watson LJ; Facundo HT; Jones SP
Amino Acids; 2011 Mar; 40(3):895-911. PubMed ID: 20798965
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy.
Papanicolaou KN; Jung J; Ashok D; Zhang W; Modaressanavi A; Avila E; Foster DB; Zachara NE; O'Rourke B
J Biol Chem; 2023 Mar; 299(3):102907. PubMed ID: 36642184
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?
Mailleux F; Gélinas R; Beauloye C; Horman S; Bertrand L
Biochim Biophys Acta; 2016 Dec; 1862(12):2232-2243. PubMed ID: 27544701
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
15. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose.
Hu Y; Suarez J; Fricovsky E; Wang H; Scott BT; Trauger SA; Han W; Hu Y; Oyeleye MO; Dillmann WH
J Biol Chem; 2009 Jan; 284(1):547-555. PubMed ID: 19004814
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
Dassanayaka S; Brittian KR; Long BW; Higgins LA; Bradley JA; Audam TN; Jurkovic A; Gumpert AM; Harrison LT; Hartyánszky I; Perge P; Merkely B; Radovits T; Hanover JA; Jones SP
PLoS One; 2020; 15(11):e0242250. PubMed ID: 33253217
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation of protein kinase A catalytic subunits enhances its activity: a mechanism linked to learning and memory deficits in Alzheimer's disease.
Xie S; Jin N; Gu J; Shi J; Sun J; Chu D; Zhang L; Dai CL; Gu JH; Gong CX; Iqbal K; Liu F
Aging Cell; 2016 Jun; 15(3):455-64. PubMed ID: 26840030
[TBL] [Abstract][Full Text] [Related]
18. Cardiac hypertrophy drives PGC-1α suppression associated with enhanced O-glycosylation.
Brainard RE; Facundo HT
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166080. PubMed ID: 33486096
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
Chun YS; Kwon OH; Chung S
Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
[TBL] [Abstract][Full Text] [Related]
20. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
